From January 28, 2022 to March 31, 2022, the company has repurchased 220,001 shares, representing 0.78% for KRW 1,670.83 million. With this, the company has completed the repurchase of 220,001 shares, representing 0.78% for KRW 1,670.83 million under the buyback announced on January 28, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6,900 KRW | +0.29% | -2.27% | +21.91% |
1st Jan change | Capi. | |
---|---|---|
+21.91% | 137M | |
+55.32% | 815B | |
-6.75% | 352B | |
+13.56% | 314B | |
+10.68% | 303B | |
+16.57% | 242B | |
+2.04% | 224B | |
+13.31% | 218B | |
+8.48% | 168B | |
-2.81% | 159B |
- Stock Market
- Equities
- A006620 Stock
- News DongKoo Bio & Pharma Co., Ltd.
- Tranche Update on DongKoo Bio&Pharma Co., Ltd.'s Equity Buyback Plan announced on January 28, 2022.